BridgeBio Pharma (BBIO) Change in Account Payables (2018 - 2026)
BridgeBio Pharma recorded quarterly Change in Account Payables of -$7.2 million in Q1 2026, down 140.91% quarter-over-quarter from $17.5 million in Q4 2025, and down 140.81% year-over-year from $17.6 million in Q1 2025.
BridgeBio Pharma's Change in Account Payables history runs 9 years deep, the most recent figure standing at -$7.2 million for Q1 2026.
- In Q1 2026, Change in Account Payables fell 140.81% year-over-year to -$7.2 million; the TTM figure through Mar 2026 stood at $1.9 million (down 92.53% YoY), while the FY2025 annual figure was $26.6 million, up 1659.85% from the prior year.
- Change in Account Payables came in at -$7.2 million for Q1 2026 at BridgeBio Pharma, down from $17.5 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $17.6 million in Q1 2025 to a low of -$7.4 million in Q3 2025.
- A 5-year average of $1.4 million and a median of -$1.1 million in 2025 frame the typical range for Change in Account Payables.
- On a YoY basis, Change in Account Payables climbed as much as 5061.41% in 2024 and fell as far as 618.88% in 2024.
- BridgeBio Pharma's Change in Account Payables stood at $1.4 million in 2022, then jumped by 349.42% to $6.2 million in 2023, then slumped by 160.56% to -$3.7 million in 2024, then jumped by 567.96% to $17.5 million in 2025, then plunged by 140.91% to -$7.2 million in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$7.2 million, $17.5 million, and -$7.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn | -7.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.17 Mn |
| Mar 31, 2026 | -7.17 Mn |
| Dec 31, 2025 | 17.53 Mn |
| Dec 31, 2025 | 17.53 Mn |
| Sep 30, 2025 | -7.43 Mn |
| Sep 30, 2025 | -7.43 Mn |
| Jun 30, 2025 | -1.06 Mn |
| Jun 30, 2025 | -1.06 Mn |
| Mar 31, 2025 | 17.57 Mn |
| Mar 31, 2025 | 17.57 Mn |
| Dec 31, 2024 | -3.75 Mn |
| Dec 31, 2024 | -3.75 Mn |
| Sep 30, 2024 | -3.60 Mn |
| Sep 30, 2024 | -3.60 Mn |
| Jun 30, 2024 | 14.79 Mn |
| Jun 30, 2024 | 14.79 Mn |
| Mar 31, 2024 | -5.93 Mn |
| Mar 31, 2024 | -5.93 Mn |
| Dec 31, 2023 | 6.18 Mn |
| Dec 31, 2023 | 6.18 Mn |
| Sep 30, 2023 | 694,000.00 |
| Sep 30, 2023 | 694,000.00 |
| Jun 30, 2023 | -298,000.00 |
| Jun 30, 2023 | -298,000.00 |
| Mar 31, 2023 | -3.80 Mn |
| Mar 31, 2023 | -3.80 Mn |
| Dec 31, 2022 | 1.38 Mn |
| Dec 31, 2022 | 1.38 Mn |
| Sep 30, 2022 | 1.37 Mn |
| Sep 30, 2022 | 1.37 Mn |
| Jun 30, 2022 | -1.28 Mn |
| Jun 30, 2022 | -1.28 Mn |
| Mar 31, 2022 | -1.81 Mn |
| Mar 31, 2022 | -1.81 Mn |
| Dec 31, 2021 | 1.47 Mn |
| Dec 31, 2021 | 1.47 Mn |
| Sep 30, 2021 | -11.67 Mn |
| Sep 30, 2021 | -11.67 Mn |
| Jun 30, 2021 | 11.23 Mn |
| Jun 30, 2021 | 11.23 Mn |
| Mar 31, 2021 | 1.79 Mn |
| Mar 31, 2021 | 1.79 Mn |
| Dec 31, 2020 | -1.28 Mn |
| Dec 31, 2020 | -1.28 Mn |
| Sep 30, 2020 | -3.44 Mn |
| Sep 30, 2020 | -3.44 Mn |
| Jun 30, 2020 | -251,000.00 |
| Jun 30, 2020 | -251,000.00 |
| Mar 31, 2020 | 4.23 Mn |
| Mar 31, 2020 | 4.23 Mn |
| Dec 31, 2019 | -1.42 Mn |
| Dec 31, 2019 | -1.42 Mn |
| Sep 30, 2019 | -3.39 Mn |
| Sep 30, 2019 | -3.39 Mn |
| Jun 30, 2019 | 2.10 Mn |
| Jun 30, 2019 | 2.10 Mn |
| Mar 31, 2019 | -1.95 Mn |
| Mar 31, 2019 | -1.95 Mn |
| Dec 31, 2018 | 7.75 Mn |
| Dec 31, 2018 | 7.75 Mn |
| Sep 30, 2018 | 97,000.00 |
| Sep 30, 2018 | 97,000.00 |